Kareem Fakhfakh is a Senior Scientist at AstraZeneca, where he leads and collaborates on pioneering projects directed towards novel manufacturing platforms of next-generation therapeutics. He has earned a patent for a novel nanoparticle-based antibody purification process, publications for advancements in mRNA manufacturing and DNA detection, and has showcased his innovations at major conferences including the ACS, BioProcess International, and International Conference on Advanced Manufacturing. Previously, he has held key roles in bio-process innovation and technology development across various organizations, with a strong track record in driving advancements in biotechnologies. Kareem holds a Master’s degree in Chemical and Biological Engineering from the University of British Columbia.